BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2024 8:03:14 AM | Browse: 214 | Download: 845
Publication Name World Journal of Clinical Oncology
Manuscript ID 94920
Country United States
Received
2024-03-28 02:20
Peer-Review Started
2024-03-28 02:20
First Decision by Editorial Office Director
2024-07-03 06:00
Return for Revision
2024-07-03 06:00
Revised
2024-07-15 00:31
Publication Fee Transferred
Editorial Processing by Scientific Editor
2024-07-23 02:44
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2024-07-23 06:39
Articles in Press
2024-07-23 06:39
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-07-25 02:54
Publish the Manuscript Online
2024-08-16 08:03
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Implications of genetic testing and informed consent before and after genetic testing in individuals with cancer
Manuscript Source Invited Manuscript
All Author List Priyanka Kumar, David J Benjamin, Sourat Darabi, Goetz Kloecker and Arash Rezazadeh Kalebasty
ORCID
Author(s) ORCID Number
David J Benjamin http://orcid.org/0000-0002-2392-886X
Arash Rezazadeh Kalebasty http://orcid.org/0000-0002-3701-5084
Funding Agency and Grant Number
Corresponding Author David J Benjamin, MD, Doctor, Doctor, Department of Medical Oncology, Hoag Family Cancer Institute, 1 Hoag Drive, Building 41, Newport Beach, CA 92663, United States. david.benjamin@hoag.org
Key Words Genetic testing; Informed consent; Genetic counseling; Next generation sequencing; Mainstreaming; Layered consent
Core Tip Mainstreaming has allowed for improved and readily available access to next generation sequencing testing in some regions of the world by allowing oncologists to order genetic testing. Pitfalls encountered with mainstreaming include adequate patient counseling on unanticipated genetic results as well as follow-up of variants of unknown significance (VUS) which have implications for tested individuals and family members. Genetic registries following VUS may provide a formal avenue for patients to receive adequate follow-up and counseling if VUS are later identified as malignant. A “layered consent model” as well as system of categorizing genes of interest may help in preserving patient autonomy and upholding the medical ethical tenets of justice and non-maleficence.
Publish Date 2024-08-16 08:03
Citation

Kumar P, Benjamin DJ, Darabi S, Kloecker G, Rezazadeh Kalebasty A. Implications of genetic testing and informed consent before and after genetic testing in individuals with cancer. World J Clin Oncol 2024; 15(8): 975-981

URL https://www.wjgnet.com/2218-4333/full/v15/i8/975.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i8.975
Full Article (PDF) WJCO-15-975-with-cover.pdf